Outcomes following Sonothrombolysis in Severe Acute Ischemic Stroke: Subgroup Analysis of the CLOTBUST Trial

Abstract

Background

Sonothrombolysis is safe and may increase the likelihood of early recanalization in acute ischemic stroke patients.

Aims

In preparation of a phase III clinical trial, we contrast the likelihood of achieving a sustained recanalization and functional independence in a post hoc subgroup analysis of patients randomized to transcranial Doppler monitoring plus intravenous tissue plasminogen activator (sonothrombolysis) compared with intravenous tissue plasminogen activator alone in the CLOTBUST trial.

Methods

We analyzed the data from all randomized acute ischemic stroke patients with pretreatment National Institutes of Health Stroke Scale scores ≥ 10 points and proximal intracranial occlusions in the CLOTBUST trial. We compared sustained complete recanalization rate (Thrombolysis in Brain Ischemia flow grades 4–5) and functional independence (modified Rankin Scale 0–1) at 90 days. Safety was evaluated by the rate of symptomatic intracranial hemorrhage within 72 h of stroke onset.

Results

Of 126 patients, a total of 85 acute ischemic stroke patients met our inclusion criteria: mean age 71 ± 11years, 56% men, median National Institutes of Health Stroke Scale 17 (interquartile range 14–20). Of these patients, 41 (48%) and 44 (52%) were randomized to intravenous tissue plasminogen activator alone and sonothrombolysis, respectively. More patients achieved sustained complete recanalization in the sonothrombolysis than in the intravenous tissue plasminogen activator alone group (38·6% vs. 17·1%; P = 0·032). Functional independence at 90 days was more frequently achieved in the sonothrombolysis than in the intravenous tissue plasminogen activator alone group (37·2% vs. 15·8%; P = 0·045). Symptomatic intracranial hemorrhage rate was similar in both groups (4·9% vs. 4·6%; P = 1·00).

Conclusions

Our results point to a signal of efficacy and provide information to guide the subsequent phase III randomized trial of sonothrombolysis in patients with severe ischemic strokes.

Keywords

clinical outcome proximal occlusion severe stroke sonothrombolysis

Get full access to this article

View all access options for this article.

References

The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995; 333: 1581–7.

Hacke

Kaste

Bluhmki

. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 2008; 359: 1317–29.

Fischer

Arnold

Nedeltchev

. NIHSS score and arteriographic findings in acute ischemic stroke. Stroke 2005; 36: 2121–5.

Heldner

Zubler

Mattle

. National Institutes of Health stroke scale score and vessel occlusion in 2152 patients with acute ischemic stroke. Stroke 2013; 44: 1153–7.

Saqqur

Uchino

Demchuk

. Site of arterial occlusion identified by transcranial Doppler predicts the response to intravenous thrombolysis for stroke. Stroke 2007; 38: 948–54.

Riedel

Zimmermann

Jensen-Kondering

Stingele

Deuschl

Jansen

. The importance of size: Successful recanalization by intravenous thrombolysis in acute anterior stroke depends on thrombus length. Stroke 2011; 42: 1775–7.

Alexandrov

Grotta

. Arterial reocclusion in stroke patients treated with intravenous tissue plasminogen activator. Neurology 2002; 59: 862–7.

Paliwal

Ahmad

Shen

. Persistence of hyperdense middle cerebral artery sign on follow-up CT scan after intravenous thrombolysis is associated with poor outcome. Cerebrovasc Dis 2012; 33: 446–52.

Smith

Lev

English

. Significance of large vessel intracranial occlusion causing acute ischemic stroke and TIA. Stroke 2009; 40: 3834–40.

10.

Sandercock

Wardlaw

Lindley

. The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): A randomised controlled trial. Lancet 2012; 379: 2352–63.

11.

Shahripour

Bavarsad R

Alexandrov

. Ancillary approaches to plasminogen activators. Ann N Y Acad Sci 2012; 1268: 113–9.

12.

Barreto

Alexandrov

. Adjunctive and alternative approaches to current reperfusion therapy. Stroke 2012; 43: 591–8.

13.

Tsivgoulis

Eggers

Ribo

. Safety and efficacy of ultrasound-enhanced thrombolysis: A comprehensive review and meta-analysis of randomized and nonrandomized studies. Stroke 2010; 41: 280–7.

14.

Ricci

Dinia

Del Sette

. Sonothrombolysis for acute ischaemic stroke. Cochrane Database Syst Rev 2012; (10): CD008348.

15.

Saqqur

Tsivgoulis

Nicoli

. The role of sonolysis and sonothrombolysis in acute ischemic stroke: A systematic review and meta-analysis of randomized controlled trials and case-control studies. J Neuroimaging 2013 Apr 22; doi: 10.1111/jon.12026.

16.

The Internet Stroke Center. Phase 3, Randomized, Placebo-Controlled, Double-Blinded Trial of the Combined Lysis of Thrombus With Ultrasound and Systemic Tissue Plasminogen Activator (tPA) for Emergent Revascularization in Acute Ischemic Stroke (CLOTBUST-ER). Available at a-randomized-active-controlled-double-blinded-trial-of-the-combined-lysis-of-thrombus-with-ultrasound-and-systemic-tissue-plasminogen-activator-tpa-for-emergent-revascularization-clotbuster-in-acute-ischemic-stroke (accessed 28 December 2013).

17.

Alexandrov

Molina

Grotta

. Ultrasound-enhanced systemic thrombolysis for acute ischemic stroke. N Engl J Med 2004; 351: 2170–8.

18.

Alexandrov

Wojner

Grotta

. CLOTBUST: Design of a randomized trial of ultrasound-enhanced thrombolysis for acute ischemic stroke. J Neuroimaging 2004; 14: 108–12.

19.

Berger

Fiorelli

Steiner

. Hemorrhagic transformation of ischemic brain tissue: Asymptomatic or symptomatic? Stroke 2001; 32: 1330–5.

20.

The NINDS t-PA Stroke Study Group. Intracerebral hemorrhage after intravenous t-PA therapy for ischemic stroke. Stroke 1997; 28: 2109–18.

21.

Alexandrov

Barlinn

Strong

Alexandrov

Aronowski

. Low-power 2-MHz pulsed-wave transcranial ultrasound reduces ischemic brain damage in rats. Transl Stroke Res 2011; 2: 376–81.

22.

Rha

Saver

. The impact of recanalization on ischemic stroke outcome: A meta-analysis. Stroke 2007; 38: 967–73.

23.

Saver

Fonarow

Smith

. Time to treatment with intravenous tissue plasminogen activator and outcome from acute ischemic stroke. JAMA 2013; 309: 2480–8.

24.

Bhatia

Hill

Shobha

. Low rates of acute recanalization with intravenous recombinant tissue plasminogen activator in ischemic stroke: Real-world experience and a call for action. Stroke 2010; 41: 2254–8.

25.

Broderick

Palesch

Demchuk

. Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. N Engl J Med 2013; 368: 893–903.

26.

Kidwell

Jahan

Gornbein

. A trial of imaging selection and endovascular treatment for ischemic stroke. N Engl J Med 2013; 368: 914–23.

27.

Ciccone

Valvassori

Nichelatti

. Endovascular treatment for acute ischemic stroke. N Engl J Med 2013; 368: 904–13.

28.

Khatri

Abruzzo

Yeatts

Nichols

Broderick

Tomsick

. Good clinical outcome after ischemic stroke with successful revascularization is time- dependent. Neurology 2009; 73: 1066–72.

29.

Hölscher

Dunford

Schlachetzki

. Prehospital stroke diagnosis and treatment in ambulances and helicopters-a concept paper. Am J Emerg Med 2013; 31: 743–7.

30.

Schlachetzki

Herzberg

Hölscher

. Transcranial ultrasound from diagnosis to early stroke treatment: Part 2: Prehospital neurosonography in patients with acute stroke: The Regensburg stroke mobile project. Cerebrovasc Dis 2012; 33: 262–71.

31.

Barreto

Alexandrov

Shen

. CLOTBUST-Hands Free: Pilot safety study of a novel operator-independent ultrasound device in patients with acute ischemic stroke. Stroke 2013; 44: 3376–81.